Guidelines for preventing and treating vitamin D deficiency: a 2023 update in Poland
P Płudowski, B Kos-Kudła, M Walczak, A Fal… - Nutrients, 2023 - mdpi.com
Introduction: All epidemiological studies suggest that vitamin D deficiency is prevalent
among the Polish general population. Since vitamin D deficiency was shown to be among …
among the Polish general population. Since vitamin D deficiency was shown to be among …
Respiratory syncytial virus infection and novel interventions
AC Langedijk, LJ Bont - Nature Reviews Microbiology, 2023 - nature.com
The large global burden of respiratory syncytial virus (RSV) respiratory tract infections in
young children and older adults has gained increased recognition in recent years. Recent …
young children and older adults has gained increased recognition in recent years. Recent …
Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants
B Kampmann, SA Madhi, I Munjal… - … England Journal of …, 2023 - Mass Medical Soc
Background Whether vaccination during pregnancy could reduce the burden of respiratory
syncytial virus (RSV)–associated lower respiratory tract illness in newborns and infants is …
syncytial virus (RSV)–associated lower respiratory tract illness in newborns and infants is …
[HTML][HTML] Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in …
M López-Lacort, C Muñoz-Quiles… - …, 2024 - eurosurveillance.org
The monoclonal antibody nirsevimab was at least 70% effective in preventing
hospitalisations in infants with lower respiratory tract infections (LRTI) positive for respiratory …
hospitalisations in infants with lower respiratory tract infections (LRTI) positive for respiratory …
[HTML][HTML] Early lessons from the implementation of universal respiratory syncytial virus prophylaxis in infants with long-acting monoclonal antibodies, Galicia, Spain …
F Martinón-Torres, S Mirás-Carballal… - …, 2023 - eurosurveillance.org
A monoclonal antibody for universal respiratory syncytial virus prophylaxis in infants has
recently been licensed. We share our experiences of integrating nirsevimab into the regional …
recently been licensed. We share our experiences of integrating nirsevimab into the regional …
Burden of respiratory syncytial virus in the European Union: estimation of RSV-associated hospitalizations in children under 5 years
M Del Riccio, P Spreeuwenberg… - The Journal of …, 2023 - academic.oup.com
Background No overall estimate of respiratory syncytial virus (RSV)-associated
hospitalizations in children aged under 5 years has been published for the European Union …
hospitalizations in children aged under 5 years has been published for the European Union …
Pediatric RSV-associated hospitalizations before and during the COVID-19 pandemic
M Bourdeau, NK Vadlamudi, N Bastien… - JAMA Network …, 2023 - jamanetwork.com
Importance Respiratory syncytial virus (RSV) is a leading cause of pediatric hospitalizations.
Objective To describe the epidemiology and burden of RSV-associated hospitalizations …
Objective To describe the epidemiology and burden of RSV-associated hospitalizations …
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a …
S Ares-Gómez, N Mallah, MI Santiago-Pérez… - The Lancet Infectious …, 2024 - thelancet.com
Summary Background Galicia (Spain) was one of the first regions worldwide to incorporate
nirsevimab for universal respiratory syncytial virus (RSV) prophylaxis in infants into its …
nirsevimab for universal respiratory syncytial virus (RSV) prophylaxis in infants into its …
Defining the Burden of Disease of RSV in Europe: estimates of RSV-associated hospitalisations in children under 5 years of age. A systematic review and modelling …
M Del Riccio, P Spreeuwenberg, R Osei-Yeboah… - medRxiv, 2023 - medrxiv.org
Background Respiratory syncytial virus (RSV) infections cause an estimated 22-50 million
episodes of acute lower respiratory infections (ALRI) every year in children younger than 5 …
episodes of acute lower respiratory infections (ALRI) every year in children younger than 5 …
Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe
Z Mao, X Li, A Dacosta-Urbieta, MN Billard… - Vaccine, 2023 - Elsevier
Background Respiratory syncytial virus (RSV) causes a considerable disease burden in
young children globally, but reliable estimates of RSV-related costs and health-related …
young children globally, but reliable estimates of RSV-related costs and health-related …